Drug recall · January 29, 2020
NETSPOT recall
Why: Defective Container: loose aluminum cap crimp for the dilution buffer vial present in the NETSPOT Kit (vial 2).
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
NETSPOT, (kit for the preparation of Ga 68 dotatate injection) 40 mcg dotatate, For Intravenous Use Only, Rx Only, Manufactured for: Advanced Accelerator Applications USA, Inc. by Gipharma S.r.l. Strada Crescentino snc, 13040 Saluggia (Vc), Italy, NDC 69488-001-40.
- Lots / codes
Lot #: PG1919025, Exp. 07/11/2020; PG1919026, PG1919027, Exp. 07/16/2020.
- Quantity
- 4295 Kits
- Company
- Advanced Accelerator Applications USA, Inc., Millburn, NJ
- Distribution
- Nationwide in the US and Canada
- Initiated
- January 10, 2020 · Voluntary: Firm initiated
- Classified
- January 22, 2020
- Reported
- January 29, 2020
- Ended
- July 21, 2023
- How notified
- Letter
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.